skip to Main Content

Medicare Part D, Part III: Impact of Policy Changes on Market Access

  • This page as PDF


Tune into the third episode of the Avalere Health Essential Voice miniseries focused on Medicare Part D. In this segment, our experts discuss policy changes currently under consideration and how stakeholders can prepare for the potential market access impacts.
“If I'm putting myself in the shoes of a manufacturer, I'm trying to get to those secondary effects that I think have the most bearing on one's strategic review and market research plans. If you look at a legislative text, you're not going to be able to glean immediately what the market responses are going to be. That’s the most important piece that's going to drive strategy.” Ryan Urgo


Ryan Urgo , Managing Director, Policy

Ryan Urgo provides strategic advice to drug manufacturers, health plans, and advocacy groups to help navigate the complex health policy environment and the impact of legislative and regulatory policies on their respective business goals.

Guest Speaker
Neil Lund , Senior Advisor, Avalere Health
Neil Lund brings more than 30 years’ worth of actuarial and formulary management experience to the firm; he works with a range of life sciences and health plan clients on issues tied to market access, patient access, and product positioning.

If you would like to watch the video version, please visit our video page.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Federal Policy
Please enter your email address to be notified when new Federal Policy insights are published.

Back To Top